Physician profile
Jin-A Yi
NPI 1275245037
$2,981.74
in general payments reported to CMS, 2019-2025
6 companies · $2,552 in 2025
The $2,552 reported for 2025 was more than what 96% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $60.12 · 2023: $206 · 2024: $163 · 2025: $2,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,628 · Food and Beverage: $1,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,628.13 |
| Food and Beverage | $1,293.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $1,119.94 | 2023-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Cardiohelp |
| Medical Device Business Services, INC. | $927.77 | 2025 | Evarrest |
| Edwards Lifesciences Corporation | $608.01 | 2022-2025 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve, Konect Resilia |
| Medtronic, INC. | $198.79 | 2022-2025 | Avalus, Endoflip, Gi Genius |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.75 | 2023-2024 | Lifevest |
| Atricure, INC. | $13.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jin-A Yi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.